Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of Cellu Tissue Holdings, Inc. - CLU
16 Septembre 2010 - 11:09PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Cellu Tissue Holdings, Inc. (“Cellu Holdings” or the
“Company”) (NYSE: CLU) for potential breaches of fiduciary duties
in connection with their conduct related to the sale of the Company
to Clearwater Paper Corporation (NYSE: CLW). The proposed
transaction offers Cellu Holdings shareholders to only receive
$12.00 in cash for each share they own. According to Thomson/First
Call, at least one financial analyst values Cellu Holdings’ common
stock at $16.00 per share.
Whether the Cellu Holdings’ Board of Directors breached their
fiduciary duties to Cellu Holdings’ stockholders by failing to
conduct an adequate and fair sales process to sell the Company
prior to agreeing to this proposed transaction, whether the
proposed transaction undervalues Cellu Holdings shares and by how
much this proposed transaction undervalues the Company to the
detriment of Cellu Holdings shareholders are the key focus of this
investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Cellu Holdings and wish to obtain
additional information, please visit us at
www.faruqilaw.com/celluholdings or contact Juan E. Monteverde, Esq.
either via e-mail at jmonteverde@faruqilaw.com or by telephone at
(877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
Real-Time news about Cellu Tissue Holdings USD0.01 (New York Stock Exchange): 0 recent articles
Plus d'articles sur Faruqi & Faruqi, LLP